Asia-Pacific Veterinary Healthcare market Segmented by products, Veterinary diagnostic technologies, Veterinary genetics, by animal types Trends & Forecasts 2016-2021

The Asia-Pacific veterinary healthcare market, estimated at USD 6.21 billion in 2016, is set to reach USD 12.12 billion by 2021, with a CAGR of 14.31% over the forecast period.

The veterinary healthcare market is gaining importance as a result of manufacturers focusing on the production of products with specialized formulations and manufacturing processes. The importance of livestock animals is generating growth in the animal healthcare market as a result of more people consuming meat and dairy products. The population boom and the stable economy are expected to result in increased demand for protein-rich foods, especially in developing regions. Animal health companies are well-positioned to address this growing emerging market demand for higher-protein diets.

Asia-Pacific Veterinary Healthcare Market- Market Dynamics

The new types of diseases in animals and their subsequent transfer to humans via animal food product consumption and companionship are escalating the veterinary healthcare industry in the Asia-Pacific region. The strategic decisions in research and development of manufacturers are expected to positively impact Asia-Pacific veterinary healthcare market.

Drivers

Some of the factors driving market growth in this region are:

• Increased love for pets leading to increased ownership
• More awareness for animal health
• Fewer requirements for animal health drugs approval
• Continuous innovations and technological advances in development of animal health drugs
• Improved nutrition
• Intensifying consumer focus on food safety
• Greater livestock production rates
• Increasing foodborne diseases
• Need to increase production of farm animal products (eggs, milk, beef and other dairy products)

Restraints

The market has the following restraining factors:

• Scarcity of arable land and water
• Increased competition for cultivated land
• Cost-effective production

In this report, the Asia-Pacific veterinary healthcare market is discussed in detail with segmentation by animal products (vaccines, parasiticides, anti-infectives, medicinal feed additives and other pharmaceuticals), animal types (companion animals, farm animals), animal diagnostic market, animal genetics market geography (China, Japan, India, South Korea, Australia and Others)

Some of the key players in the market are:

• Bayer Healthcare
• Boehringer Ingelheim
• Ceva Animal Health, Inc.
• Elanco
• Merck
• Merial (Animal Health Division of Sanofi)
• Virbac

What the Report Offers

• Market definition for the Asia-Pacific veterinary healthcare market along with identification of key drivers and restraints for the market.
• Market analysis for the Asia-Pacific veterinary healthcare market, with region-specific assessments and competition analysis on a global and regional scale.
• Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
• Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share. 
• Identification and analysis of the macro and micro factors that affect the Asia-Pacific veterinary healthcare market on both global and regional scale.
• A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
• The report provides competitive intelligence analysis in the form of mergers and acquisition activity, collaborations, agreements, new product launches along with the profiles of major players.